Oxidized derivatives of 7-dehydrocholesterol induce growth retardation in cultured rat embryos: A model for antenatal growth retardation in the Smith-Lemli-Opitz syndrome

Journal of Lipid Research

Volumn 40, Issue 3, 1999, Pages 456-463

  Gaoua, Wassila ^a   Chevy, Françoise ^b   Roux, Charles ^a   Wolf, Claude ^b  

^a SORBONNE UNIVERSITÉ   (France)

^b CNRS   (France)

Author keywords

AY9944; Cholesterol lecithin liposomes; UV photooxidation; Vitamin E

Indexed keywords

1,4 BIS(2 CHLOROBENZYLAMINOMETHYL)CYCLOHEXANE; 7 DEHYDROCHOLESTEROL; ALPHA TOCOPHEROL; CHOLESTEROL; CHOLESTEROL DERIVATIVE; STEROID REDUCTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; EMBRYOTOXICITY; FETUS; FETUS GROWTH; INTRAUTERINE GROWTH RETARDATION; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PHOTOOXIDATION; PRIORITY JOURNAL; RAT; SMITH LEMLI OPITZ SYNDROME; ULTRAVIOLET IRRADIATION;

ANIMALS; ANTIOXIDANTS; CHOLESTEROL; DEHYDROCHOLESTEROLS; DISEASE MODELS, ANIMAL; EMBRYO; EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; GROWTH; ORGAN CULTURE TECHNIQUES; OXIDATION-REDUCTION; OXIDOREDUCTASES; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; RATS; RATS, WISTAR; SMITH-LEMLI-OPITZ SYNDROME; TERATOGENS; TRANS-1,4-BIS(2-CHLOROBENZAMINOMETHYL)CYCLOHEXANE DIHYDROCHLORIDE; ULTRAVIOLET RAYS; VITAMIN E;

EID: 0032969402     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Smith, D. W., D. Lemli, and J. M. Opitz. 1964. A newly recognized syndrome of multiple congenital anomalies. J. Pediatr. 64: 210-217.
2. Tint, G. S. 1993. Cholesterol defect in Smith-Lemli-Opitz syndrome. Am. J. Med. Genet. 47: 573-574.
3. Salen, G., S. Shefer, A. K. Batta, G. S. Tint, G. Xu, A. Honda, M. Iron, and E. R. Elias. 1996. Abnormal cholesterol biosynthesis in the Smith-Lemli-Opitz syndrome. J. Lipid Res. 37: 1169-1180.
4. Cormier-Daire, V., C. Wolf, A. Munnich, M. Le Merrer, A. Nivelon, D. Bonneau, H. Journel, F. Fellmann, F. Chevy, and C. Roux. 1996. Abnormal cholesterol biosynthesis in the Smith-Lemli-Opitz and the lethal acrodysgenital syndromes. Eur. J. Pediatr. 155: 656-659.
5. Roux, C., and M. Aubry. 1966. Action teratogéne chez le rat d'un inhibiteur de la synthése du cholesterol, le AY 9944. C. R. Soc. Biol. 160: 1353-1357.
6. Polonovski, J., J. C. Maziere, C. Maziere, L. Mora, F. Gallie, J. Gardette, V. Barbu, and C. Roux. 1986. Effects of amphiphilic drugs on low density lipoprotein and sterol metabolism in cultured human fibroblasts. In Lipid Metabolism and Its Pathology. M. J. Halpern, editor. Elsevier Science Publishers B.V. 19-27.
7. 7-reductase gene at 11q12-13 cause Smith-Lemli-Opitz syndrome. Am. J. Hum. Genet. 63: 55-62.
8. Honda, A., G. S. Tint, G. Salen, A. K. Batta, T. S. Chen, and S. Shefer. 1995. Defective conversion of 7-dehydrocholesterol to cholesterol in cultured skin fibroblasts from Smith-Lemli-Opitz syndrome homozygotes. J. Lipid Res. 36: 1595-1601.
9. Tint, G. S., M. Seller, R. Hughes-Benzie, A. K. Batta, S. Shefer, D. Genest, M. Irons, E. Elias, and G. Salen. 1995. Markedly increased tissue concentrations of 7-dehydrocholesterol combined with low levels of cholesterol are characteristic of the Smith-Lemli-Opitz syndrome. J. Lipid Res. 36: 89-95.
10. Irons, M., E. R. Elias, G. S. Tint, G. Salen, and A. K. Batta. 1993. Defective cholesterol biosynthesis in Smith-Lemli-Opitz syndrome. Lancet. 341: 1414.
11. Irons, M., E. R. Elias, G. S. Tint, G. Salen, R. Frieden, T. M. Buie, and M. Ampola. 1994. Abnormal cholesterol metabolism in the Smith-Lemli-Opitz syndrome: report of clinical and biochemical findings in four patients and treatment in one patient. Am. J. Med. Genet. 50: 347-352.
12. Tint, G. S., M. Irons, E. R. Elias, A. K. Batta, R. Frieden, T. S. Chen, and G. Salen. 1994. Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. N. Engl. J. Med. 330: 107-113.
13. Batta, A. K., S. Tint, S. Shefer, D. Abuelo, and G. Salen. 1995. Identification of 8-dehydrocholesterol (cholesta-5,8-dien-3β-ol) in patients with Smith-Lemli-Opitz syndrome. J. Lipid Res. 36: 705-713.
14. Batta, A. K., G. Salen, S. Tint, and S. Shefer. 1995. Identification of 19-nor-5,7,9(10)-cholestatrien-3β-ol in patients with Smith-Lemli-Opitz syndrome. J. Lipid Res. 36: 2413-2418.
15. Ruan, B., J. Shey, N. Gerst, W. K. Wilson, and G. J. Schroepfer. 1996. Silver ion high pressure liquid chromatography provides unprecedented separation of sterols: Application to the enzymatic formation of cholesta-5,8-dien-3β-ol. Proc. Natl. Acad. Sci. USA. 93: 11603-11608.
16. Ruan, B., J. Pang, W. K. Wilson, and G. J. Schroepfer. 1996. Concerning the thermostability of cholesta-5,8-dien-3β-ol, a sterol that accumulates in blood and tissues in a human genetic developmental disorder. Bioorg. Med. Chem. Lett. 20: 2421-2424.
17. Llirbat, B., C. Wolf, F. Chevy, D. Citadelle, G. Bereziat, and C. Roux. 1997. Normal and inhibited cholesterol synthesis in the cultured rat embryo. J. Lipid Res. 38: 22-34.
18. 7 reductase by novel 6-aza-B-homosteroids and other analogs of a presumptive carbocationic intermediate of the reduction reaction. Biochemistry. 35: 7069-7076.
19. Chiang, C., Y. Litingtung, E. Lee, K. E. Young, J. L. Corden, H. Westphal, and P. A. Beachy. 1996. Cyclopia and defective axial patterning in mice lacking Sonic Hedgehog gene function. Nature. 383: 407-413.
20. Porter, J. A., K. E. Young, and P. A. Beachy. 1996. Cholesterol modification of Hedgehog signaling protein in animal development. Science. 274: 255-259.
21. Kelley, R. I., E. Roessler, R. C. M. Hennekam, G. L. Feldman, K. Kosaki, M. C. Jones, J. C. Palumbos, and M. Muenke. 1996. Holoprosencephaly in RSH/Smith-Lemli-Opitz Syndrome: does abnormal cholesterol metabolism affect the function of Sonic Hedgehog? Am. J. Med. Genet. 66: 478-484.
22. Roessler, E., E. Belloni, K. Gaudenz, P. Jay, B. Berta, S. W. Sherer, L. C. Tsui, and M. Muenke. 1996. Mutations in the human sonic hedgehog gene cause holoprosencephaly. Nat. Genet. 14: 357-360.
23. Martin, G. 1996. Pass the butter . . . Science. 274: 203-204.
24. Cooper, M. K., J. A. Porter, K. E. Young, and P. A. Beachy. 1998. Teratogen-mediated inhibition of target tissue response to Shh signaling. Science. 280: 1603-1607.
25. Muenke, M., R. C. M. Hennekam, and R. I. Kelley. 1994. Holoprosencephaly as a manifestation in Smith-Lemli-Opitz syndrome. Am. J. Hum. Genet. 55: A36.
26. Roux, C., C. Horvath, and R. Dupuis. 1979. Teratogenic action and embryolethality of AY9944 in rats. Prevention by a hypercholesterolemia-provoking diet. Teratology. 19: 35-38.
27. Barbu, V., C. Roux, D. Lambert, R. Dupuis, J. Gardette, J. C. Maziere, E. Elefant, and J. Polonovsky. 1988. Cholesterol prevents the teratogenic action of AY 9944: importance of the timing of cholesterol supplementation to rats. J. Nutr. 118: 1411-1416.
28. Farese, R. V., S. Cases, S. L. Ruland, H. J. Kayden, J. S. Wong, S. G. Young, and R. L. Hamilton. 1996. A novel function for apolipoprotein B: lipoprotein synthesis in the yolk sac is critical for maternal-fetal lipid transport in mice. J. Lipid Res. 37: 347-360.
29. Lanoue, L., D. B. Dehart, S. Tint, N. Maeda, and K. K. Sulik. 1996. Gene environment interactions in cholesterol deficiency-based malformations. Teratology. 53: A26, 89.
30. Willnow, T. E., J. Hilpert, S. A. Armstrong, A. Rohlmann, R. E. Hammer, D. K. Burns, and J. Herz. 1996. Defective forebrain development in mice lacking gp330/megalin. Proc. Natl. Acad. Sci. USA. 93: 8460-8464.
31. De Fabiani, E., D. Caruso, M. Cavaleri, M. Galli Kienle, and G. Galli. 1996. Cholesta-5,7,9(11)-trien-3β-ol found in plasma of patients with Smith-Lemli-Opitz syndrome indicates formation of sterol hydroperoxide. J. Lipid Res. 37: 2280-2287.
32. Miller, S. C., and G. Melnykovych. 1984. Regulation of cholesterol biosynthesis and esterification by 25-hydroxycholesterol in a macrophage-like cell line: uncoupling by progesterone. J. Lipid Res. 25: 991-999.
33. Bell, J. J., T. E. Sargeant, and J. A. Watson. 1976. Inhibition of 3-hydroxy-methylglutaryl coenzyme A reductase in hepatoma tissue culture cells by pure cholesterol and several cholesterol derivatives. Evidence supporting two distinct mechanisms. J. Biol. Chem. 251: 1745-1758.
34. Honda, M., G. S. Tint, A. Honda, L. B. Nguyen, T. S. Chen, and S. Shefer. 1998. 7-Dehydrocholesterol down-regulates cholesterol biosynthesis in cultured Smith-Lemli-Opitz syndrome skin fibroblasts. J. Lipid Res. 39: 647-657.
35. Lin, D. S., R. M. Pitkin, and W. E. Connor. 1977. Placental transfer of cholesterol into the human fetus. Am. J. Obstet. Gynecol. 128: 735-739.
36. Parker, C. R., T. Deahl, P. Drewry, and G. Hankins. 1983. Analysis of the potential for transfer of lipoprotein-cholesterol across the human placenta. Early Hum. Dev. 8: 289-295.
37. New, D. A. T. 1978. Whole-embryo culture and the study of mammalian embryos during organogenesis. Biol. Rev. 53: 81-122.
38. Brown, N. A., and S. Fabro. 1981. Quantification of rat development in vitro: a morphological scoring system. Teratology. 24: 65-78.
39. Albro, P. W., P. Bilski, J. T. Corbett, J. L. Schroeder, and C. F. Chignell. 1997. Photochemical reactions and phototoxicity of sterols: novel self-perpetuating mechanisms for lipid photooxidation. Photochem. Photobiol. 66: 316-320.
40. Anderson, A. J., M. J. Stephan, W. O. Walker, and R. I. Kelley. 1998. Variant RSH/Smith-Lemli-Opitz syndrome with atypical sterol metabolism. Am. J. Med. Genet. 78: 413-418.
41. 7-reductase inhibitors: comparison to levels in humans with Smith-Lemli-Opitz syndrome. J. Lipid Res. 37: 1325-1333.
42. Repetto, M., J. C. Maziére, D. Citadelle, R. Dupuis, M. Meier, S. Biade, D. Quiec, and G. Roux. 1990. Teratogenic effect of the cholesterol synthesis inhibitor AY 9944 on rat embryos in vitro. Teratology. 42: 611-618.
43. Lange, Y., J. Ye, and T. L. Steck. 1998. Circulation of cholesterol between lysosomes and the plasma membrane. J. Biol. Chem. 273: 18915-18922.
44. Sevenian, A., and L. L. McLeod. 1987. Cholesterol autooxidation in phospholipid membrane bilayers. Lipids. 22: 627-636.
45. Incardona, J. P., W. Gaffield, R. P. Kapur, and H. Roelink. 1998. The teratogenic Veratrum alkaloid cyclopamine inhibits Sonic hedgehog signal transduction. Development. 125: 3553-3562.
46. Wyne, K. L., and L. A. Woollett. 1998. Transport of maternal LDL and HDL to the fetal membranes and placenta of the Golden Syrian hamster is mediated by receptor-dependent and receptor-independent processes. J. Lipid Res. 39: 518-530.